Luchnikova T.A., Prikhodko O.B., Voytsekhovskiy V.V.
Correlation between vitamin D concentration and severity of community-acquired pneumonia in patients from the Amur region
|
№10 / 2023
|
Kokorin V.A., Larina V.N., Lunev D.I., Suvorova N.A.
Based on materials of community-acquired pneumonia – an European Federation of Internal Medicine guideline critical appraisal adaptation for internists: Important answers to difficult questions
|
№6 / 2023
|
Karnaushkina M.A., Baisultanova R.E.-P., Osmanov E.M., Akaeva S.M., Elzhurkaeva L.R., Tokaeva M.R.
Analysis of markers associated with unfavorable clinical outcomes in the process of hospital therapy of community-acquired pneumonia in patients with type 2 diabetes mellitus
|
№3 / 2023
|
Malyavin A.G.
Vaccine prophylaxis of pneumococcal infection: what a therapist needs to know (overview of the symposium within the XVI National Congress of Internists)
|
№10 / 2021
|
Larina V.N., Bondarenkova A.A.
Clinical observation of a young patient with obesity and COVID-19-associated lung tissue damage
|
№8 / 2020
|
Izmozherova N.V., Popov A.A., Gavrilova E.I., Kuryndina A.A., Tagiltseva N.V. Shambatov M.A.
Community-acquired pneumonia course peculiarities in comorbid patients hospitalized during the epidemic of respiratory viral infections
|
№6 / 2020
|
Bulatova E.M., Nesterenko Z.V.
Community-aquired pneumonia in asthmatic children with different duration of inhaled corticosteroid therapy
|
№7 / 2019
|
A.A. Zaitzev
Community-acquired pneumonia: epidemiology, diagnostics and antimicrobal therapy
|
№1 / 2018
|
T.A. Ruzhentsova, A.A. Ploskireva
Choice of tactics of patients with community-acquired pneumonia
|
№1 / 2016
|